Search clinical trials for: Surgically Eligible Basal Cell Carcinomas

Total 54586 results

Sol-Gel Technologies, Ltd.

Terminated

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Basal Cell Nevus Syndrome

United States, France, Belgium, Denmark, Germany, Italy, Netherlands, Spain, United Kingdom
Sol-Gel Technologies, Ltd.

Terminated

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Recurrent Basal Cell Carcinoma

United States
PellePharm, Inc.

Completed

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Basal Cell Nevus Syndrome

United States, Spain, Germany, United Kingdom, Italy, France, Belgium, Canada, Denmark, Netherlands
PellePharm, Inc.

Completed

Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients

Basal Cell Nevus Syndrome

United Kingdom
PellePharm, Inc.

Completed

Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas (BCC)

Basal Cell Carcinomas

United States
Damae Medical

Not yet recruiting

Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas (ECOBASO)

Basal Cell Carcinoma of the Skin

France
Sol-Gel Technologies, Ltd.
Premier Research Group plc

Recruiting

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Gorlin Syndrome

United States
Bispebjerg Hospital
Mirai Medical, Ireland

Recruiting

Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Basal Cell Carcinoma

Denmark
Palvella Therapeutics, Inc.

Recruiting

CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

BCCs in Gorlin Syndrome Patients

United States, United Kingdom
Institut Curie

Recruiting

LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG (LIBERTYLUNG)

NSCLC Patient in a Metastatic Stage Eligible for First-line Treatment With Immune Checkpoint Inhibitor

France
University Hospital, Bordeaux
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions (MITOSKIN)

Basal Cell Carcinomas | Cutaneous Squamous Cell Carcinoma

France
University Hospital, Ghent
Erasmus Medical Center

Enrolling by invitation

HRQoL Keratinocyte Carcinomas

Actinic Keratoses | Basal Cell Carcinoma | Squamous Cell Carcinoma

Belgium, Netherlands
Oslo University Hospital

Enrolling by invitation

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

Basal Cell Carcinoma | Gorlin Syndrome

Norway
Ascend Biopharmaceuticals Ltd

Suspended

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

Basal Cell Carcinoma in Basal Cell Nevus Syndrome

United States
Galderma R&D

No longer available

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

Basal Cell Carcinoma | Bowen's Disease | Field Actinic Keratoses
UCSF Benioff Children's Hospital Oakland
Genentech, Inc.

Completed

Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas (Vismodegib)

Basal Cell Nevus Syndrome | Gorlin's Syndrome

United States
Bispebjerg Hospital

Unknown

Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas

Immune Response | Immunotherapy | BCC - Basal Cell Carcinoma | Ablative Fractionated Laser

Denmark
Julie Dawson
Mavig GmbH

Completed

Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery (FCM-P)

Basal Cell Carcinoma

United Kingdom
University of Arizona

Terminated

Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention

Basal Cell Carcinomas

United States
Stanford University

Completed

Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas

Skin Cancer | Basal Cell Carcinoma (BCC)

United States
University of Arizona
Genentech, Inc.

Completed

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas (PDT-Vismo)

Basal Cell Carcinoma

United States
Merete Haedersdal
LEO Pharma

Completed

Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate

Carcinoma, Basal Cell

Denmark
Hoffmann-La Roche

Completed

A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

Basal Cell Carcinoma

United States, Spain, France, Germany, Netherlands, Russian Federation, Italy, Mexico, Austria, Canada
Norwegian University of Science and Technology

Completed

Debulking Effect of Curretage on Basal Cell Carcinomas - a Histological Assessment.

Carcinoma, Basal Cell
Thomas Jefferson University
Advanced Aesthetics

Unknown

Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas

Basal Cell Carcinoma

United States
Novartis Pharmaceuticals

Completed

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients

Austria, Switzerland
Novartis Pharmaceuticals

Terminated

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

Sporadic Superficial and Nodular Skin Basal Cell Carcinomas

Austria, Australia
Bispebjerg Hospital

Completed

Fractional CO2 Laser Assisted Photodynamic Therapy

Actinic Keratosis | Basal Cell Carcinoma

Denmark
Hautklinik Darmstadt
University Medicine Greifswald

Completed

Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas

Basal Cell Carcinoma
UCSF Benioff Children's Hospital Oakland

Completed

Development of a Nanosecond Pulsed Electric Field System to Treat Skin Cancer (NPEF)

Basal Cell Carcinomas

United States
University of Ioannina

Completed

Treatment of Primary Basal Cell Carcinomas of the Skin With Combination of Topical Imiquimod and Cryosurgery (IMCX)

Basal Cell Carcinoma

Greece
Rambam Health Care Campus

Completed

Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

Basal Cell Carcinoma
Bispebjerg Hospital

Unknown

Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

Photodynamic Therapy | Basal Cell Carcinomas

Denmark
QLT Inc.
Novartis

Terminated

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

Nevoid Basal Cell Carcinoma Syndrome | Basal Cell Carcinoma | Gorlin Syndrome
University Hospital Tuebingen

Suspended

Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas

Carcinoma, Basal Cell

Germany
Hospital Ambroise Paré Paris

Unknown

Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC) (BACHIMO)

Carcinoma, Basal Cell

France
University Hospital Tuebingen

Unknown

Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970

Carcinoma, Basal Cell

Germany
National Cancer Institute (NCI)

Completed

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

Psoriasis | Basal Cell Carcinoma | Keratosis Palmaris et Plantaris

United States
Centre Leon Berard

Not yet recruiting

Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO) (TACO)

Oral Squamous Cell Carcinomas

France
Highlight Therapeutics

Recruiting

Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC) (SPOTLIGHT204)

Basal Cell Carcinoma

Israel
University of Haifa
Bnai Zion Medical Center; Clalit Health Services, Haifa and West Galilee

Not yet recruiting

Risk and Clinical Consequences of Low Count Monoclonal B-cell Lymphocytosis (LC MBL) (MBL RiskConseq)

Cardiovascular Diseases | Infections | Autoimmune Diseases | Parkinson Disease | Dementia | Alzheimer Disease | Chronic Lymphocytic Leukemia | Monoclonal B-Cell Lymphocytosis | Cancers
National Cancer Institute (NCI)

Not yet recruiting

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Carcinoma, Neuroendocrine | Tumor, Neuroendocrine | Tumors, Neuroendocrine | Neuroendocrine; Carcinoma | Small Cell; Receptors

United States
Rise Therapeutics LLC

Not yet recruiting

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Melanoma | Basal Cell Carcinoma | Squamous Cell Carcinoma | Melanoma Recurrent | Squamous Cell Cancer | Basal Cell Cancer
Renee Cattell

Not yet recruiting

Raman Spectroscopy and Skin Cancer

Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma

United States
Kantonsspital Winterthur KSW
Luzerner Kantonsspital

Not yet recruiting

Skin Cancer and Hyperthermia and Radiotherapy (SAHARA)

Basal Cell Carcinoma | Non-melanoma Skin Cancer | Squamous Cell Carcinoma Skin

Switzerland
University of Pennsylvania

Not yet recruiting

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Parkinson Disease | Alzheimer Disease | ALS | Polyneuropathies | Frontotemporal Dementia | Pheochromocytoma | Thoracic Aortic Aneurysm | Paraganglioma | Genetic Predisposition | Cardiomyopathy Non-ischemic
University Hospital, Toulouse
Janssen, LP; Ligue contre le cancer, France

Not yet recruiting

Real-life Management of Patients Eligible for CAR-T Cell Therapy (CARAVAGE)

Hemopathy

France
University of Michigan Rogel Cancer Center

Not yet recruiting

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer (NEPTUNE)

Urothelial Carcinoma

United States
Stamford Pharmaceuticals, Inc.

Recruiting

To Assess the Safety and Efficacy of SP-002 With Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Basal Cell Carcinoma

United States
Region Örebro County

Recruiting

Dermatoscopy Guided Resection for Skin Cancer

Basal Cell Carcinoma | Surgical Margin | Cutaneous Squamous Cell Carcinoma

Sweden

Search clinical trials for: Surgically Eligible Basal Cell Carcinomas

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations